Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
BOTSWANA – Botswana has approved the use of injectable anti-retroviral (ARV) drugs to improve adherence to HIV treatment. With the world’s fourth largest prevalence of HIV infections, Botswana becomes the…
Read More
BOTSWANA – Industrial manufacturers of branded medicines Roche, in collaboration with Orthosurge Botswana and Diagnofirm, has inaugurated the cobas® 5800 molecular diagnostics system in Gaborone. The system will expand molecular…
Read More
ZIMBABWE – The World Health Organization (WHO) has announced that Zimbabwe has approved the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV (human immunodeficiency virus). Speaking…
Read More
NIGERIA – The United States Agency for International Development (USAID) has received contribution from the Abdul Samad Rabiu Africa Initiative (ASR Africa) to bolster tuberculosis (TB) control and gender-based violence…
Read More
GHANA – The National Sexually Transmitted Infections (STIs) and HIV/AIDs Control Programme (NACP) has warned about the rise in new infections with HIV and AIDS-related deaths in Ghana. According to…
Read More
AFRICA – African Ministers of Health have joined forces with global health institutions and partners to sustain their commitments to end AIDS as well as accelerate their response to current…
Read More
KENYA – The Masinde Muliro University of Science and Technology (MMUST) and the Immunify.Life, a transformative blockchain-based healthcare ecosystem, have formally launched a blockchain-based HIV/AIDS treatment outcomes study in Kenya.…
Read More
AFRICA – A new easy-to-use device for infant circumcision dubbed ShangRing has proved to be safe and could boost HIV (human immunodeficiency virus) prevention efforts in Africa, the highly-ranked Ivy…
Read More
KENYA – Kenya’s Ministry of Health has announced plans to implement a three-test HIV testing algorithm as the country seeks to optimize ongoing efforts to deal with the virus, the…
Read More
USA- The European Commission has approved Sunlenca® (lenacapavir) for use every six months along with other antiretrovirals to treat adults with HIV infections. Lenacapavir is a first-in-class capsid inhibitor with…
Read More